Sanofi Doubles Down on Artificial Intelligence Integration to Accelerate Pharmaceutical Research and Drug Discovery
The French pharmaceutical titan is executing a massive corporate restructuring designed to embed artificial intelligence across its entire research and development pipeline, seeking to drastically reduce the time and capital required to bring complex new therapeutics to global markets.